p aroxysmal nocturnal hemoglobinuria (PNH) is a hematologic disorder caused by an acquired deficiency of the glycosyl phosphatidylinositol (GPI) anchor biosynthesis (1) (2) (3) (4) . Defidencies of GPI-anchored complement regulatory proteins, decay-accelerating factor (DAF) and 20-kD homologous restriction factor (CD59), both of which inhibit complement activation on the host cell surface and thereby protect host cells from destructive action of complement, are causally related to intravascular hemolysis, a major clinical symptom (5) . The deficiency of GPI-anchored proteins is found in different lineages of hematopoietic cells including lymphocytes (6) (7) (8) (9) . It is, therefore, thought that a somatic mutation has occurred in the multipotential hematopoietic stem cell, which gives rise to affected blood cells and lymphocytes. Biosynthesis of the GPI anchor involves multiple reaction steps, being represented by several complementation classes of GPI anchor-deficient mutant cell lines (10) . Defects of many of them have been biochemically characterized (11) (12) (13) (14) (15) . Cells of three different complementation classes, A, C, and H, do not synthesize an early intermediate, N-acetylglucosaminyl-phosphatidylinositol (GlcNAc-PI), indicating that these early complementation classes define different genes, all of which must be necessary for biosynthesis of this glycolipid. Other classes, such as B and F, have defects in the later reaction steps. We recently established affected cell lines from two Japanese patients with PNH (16) . In the present study we demonstrated that those cell lines belong to the complementation class A. Analysis of glycolipid biosynthesis confirmed that those PNH cell lines in fact do not synthesize GlcNAc-PI.
Materials and Methods
Cells and Culture GPI anchor-defident cell lines (SS-I-, TK-I-, and TK-14-) and wild-type cell lines (SS-2 + and TK-4 +) established from two Japanese patients with PNH (patients SS and TK) were described previously (16) . Thy-l-deficient routine thymoma cell lines, BW5147(Thy-l-a), S49(Thy-l-a), AKRI(Thy-I-a), S1A(Thy-l-b), T1Ml(Thy-l-c), AKR.I(Thy-I-d), BW5147(Thy-l-e), EL-4(Thy-l-f), and S49(Thy-l-h), were described previously (17) (18) (19) (20) (21) . A Japanese Burkitt's lymphoma cell line, P32/Ishida (22) , was a gift from Dr. T. Seya (Center for Adult Diseases, Osaka, Japan) and a GPI anchor-deficient cell line, P32-2D2, derived from P32/Ishida was established in our laboratory by ethylmethanesulfonate treatment followed by flow-cytometric sorting of CD59-negative cells and cloning by limiting dilution. All cell lines were cultured in DMEM containing 10% FCS. Biosynthesis of the GPI Anchor Intermediates. Cell lysates were prepared as described previously (23) . The lysates (107 cell equivalent) were incubated with 2 #Ci of UDP-6-[3H]GlcNAc (American Radiolabeled Chemicals, St. Louis, MO) for 15 min at 37~ in the presence of tunicamycin (23) . n-Butanol soluble lipid fraction was subjected to thin-layer chromatography on silica gel with a solvent consisting of chloroform, methanol, and 1 M NH4OH (10:10:3) (23). The gel was treated for fluorography. Aliquots of the lipid fraction were treated with phosphatidylinositol-specific phospholipase C (PI-PLC) and HNO2, respectively, to confirm presence of PI and nonacetylated glucosamine (23) . The lysates were also incubated with GDP-2-[3H]mannose for 90 min at 37~ as described previously (24) . In vivo labeling of cells with [3H]mannose was done as described (24) .
Complementation Analysis with Somatic

Results
Determination of the Complementation Class of the Cell Lines
Established from Patients with PNH. The SS-1-cells were fused with Thy-l-deficient murine thymoma cells of complementation classes A, B, C, D, E, F, and H, and heterokaryons were assessed for surface expression of CD59 (Fig.  i and Table 1 ). Surface expression of CD59 was complemented on fusion with classes B, C, D, E, F, and H, but not with class A, indicating that SS-1-cells belong to complementation class A. Further analysis with two other murine class A thymoma cell lines confirmed this result (Table 1) . A similar study performed with another PNH cell line demonstrated that TK-14-cells also belong to class A (Table 1) . Fusion between SS-1-and TK-14-cells did not complement surface expression of CD59, confirming that these PNH cell lines that were established from different patients belong to the same class. Surface expression of CD59 was complemented when class A murine thymoma cells were fused with a GPI anchor-deficient human cell line, P32-2D2 (Table 1) . This excludes a possibility that the lack of complementation between class A murine cells and the PNH cell lines was due to species incompatibility.
Deficient Biosynthesis of GlcNAc-PI in SS-1-and TK14-
Cells.
The above results demonstrated that the two PNH cell lines belong to complementation class A. We, therefore, analyzed biosynthesis of the GPI anchor intermediates in SS-1-, TK-1-, and TK-14-cells. Since previous studies on class A murine thymoma cells indicated that they do not synthesize GIcNAc-PI, the first intermediate of the biosynthetic pathway, we first focused on the early steps of the biosynthesis. Incubations of the radiolabeled donor of GlcNAc, UDP-6-[3H]GlcNAc, with cell lysates of GPI anchor-sufficient cell lines, SS-2 + and TK-4*, established from the same patients as SS-1-and TK-14-resulted in synthesis of GlcNAc-PI and its subsequent deacetylation to glucosaminyl-phosphatidylinositol (GlcN-PI) (Fig. 2, lanes 2 and 4) . The identities of these spots were confirmed by assessing their sensitivities to PI-PLC and HNO2 (data not shown). In contrast, cell lysates of deficient cell lines, SS-1 -, TK-1 -, and TK-14-, did not support biosynthesis of GlcNAc-PI (Fig. 2, lanes 1, 3 , and 5), being consistent with the above complementation analyses and previous reports on the biosynthetic defect of routine class A cells. Being consistent with these results, both in vitro and in vivo analyses of mannolipid biosynthesis demonstrated that these deficient cell lines are able to synthesize dolicholphosphate-mannose, a donor of mannose, but are not able to synthesize significant amounts of mannose-containing intermediates in GPI anchor biosynthesis (data not shown).
Discussion
In the present study we have characterized for the first time the exact biochemical defect of affected cells from patients with PNH. We previously established cell lines from two Japanese patients with PNH (16) . The established GPIanchored protein-deficient cell lines had the phenotype of PNH: (a) deficiency of surface expressions of multiple GPIanchored proteins; (b) normal transcription of the DAF gene; and (c) intraceUular biosynthesis of precursor peptides of DAF and CD59. To characterize the biochemical defect of these GPI anchor-deficient cell lines two approaches were undertaken. First, these cell lines were fused with GPI anchor-deficient mutant cell lines of known biochemical defects to assess complementation of the surface expression of GPIanchored proteins. Second, biosynthesis of glucosaminecontaining glycolipids was analyzed in an in vitro system using cell lysates and the radioactive sugar nucleotide. The complementation analysis demonstrated that both cell lines had the same defect as mutant cells of class A, which is one of the three "early mutants" that do not synthesize GlcNAc-PI ( Fig. I and Table 1 ). The biosynthetic analysis provided independent and consistent evidence that GlcNAc-PI is not synthesized in these PNH cell lines (Fig. 2) . It is, therefore, concluded that an early step in the biosynthesis of GPI anchor is deficient in these affected cell lines established from two Japanese patients.
It seems reasonable to assume that a defect in any one of the genes in the biosynthetic pathway of the GPI anchor causes a similar clinical disorder. Previous analysis of the GPI anchor biosynthesis in the affected neutrophils from several American patients with PNH indicated that biosynthesis of GIcNAc-PI and its subsequent deacetylation are normal (23) , but that biosynthesis of mature GPI anchor is markedly reduced or virtually negative in affected neutrophils (4), suggesting the presence of an abnormality in the later reaction sequence. However, more recent analysis showed that deficient T cell lines obtained from one of these American patients and from other patients with PNH do not synthesize GlcNAc-
